Mepilex® Ag is an absorbent foam dressing featuring Safetac® technology and silver. Effective antimicrobial activity for up to seven days.
• Inactivates wound pathogens within 30 minutes and for up to seven days
• Inactivates a broad range of pathogens, including MRSA
• Excellent conformability for better patient comfort and dressing fit
• Good exudate management properties
• Can be cut to suit various wound sizes and difficult-to-dress areas
Mepilex® Ag is indicated for the management of low to moderately exuding wounds such as leg and foot ulcers, pressure ulcers and partial-thickness burns.
|Absorptive dressing format|
|Alginate dressing format|
|Antimicrobial effects up to 3 days|
|Antimicrobial effects up to 48 hours|
|Antimicrobial effects up to 7 days||●|
|Collagen dressing format|
|Composite dressing format|
|Contact layer dressing format|
|Foam dressing format||●|
|Gauze or non-woven dressing format|
|Hydrogel (amorphous) dressing format|
|Hydrogel (impregnated) dressing format|
|Hydrogel (sheet) dressing format|
|Impregnated dressing format|
|Moisture vapor permeable||●|
|Secondary dressing required|
|Sustained release formula||●|
|Wound filler dressing format|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Clean the wound area. Remove the release film. Mepilex® Ag should overlap the wound bed by at least 2cm onto the surrounding skin. Apply the adherent side to the wound. Do not stretch. When necessary, secure Mepilex® Ag with a bandage or other fixation.
Mölnlycke Health Care US is the supplier of innovative, high-quality wound management products that provide a holistic and caring approach to the patient and to gentle wound healing. Safetac® products feature a unique, patented soft silicone technology.